We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Conducting Trials Abroad Should Be Cautious of FCPA
Sponsors Conducting Trials Abroad Should Be Cautious of FCPA
February 2, 2011
Sponsors conducting clinical trials outside the U.S. can expect increased scrutiny as the federal government looks to prosecute companies in violation of the Foreign Corrupt Practices Act (FCPA), according to a Justice Department official.